Home/ Supplements/ Iron/ Mega-One No Iron

Mega-One No Iron

product on market Tablet or Pill Source Naturals Safety: 98/100
98/100

This product looks safe

  • Niacinamide: 85mg is 2.4× the Tolerable Upper Intake Level (35mg)
  • Folate: 714mg is 714.0× the Tolerable Upper Intake Level (1.0mg)
  • 61% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile includes essential vitamins such as A, C, D3, and E, which are supported by strong evidence for maintaining immune function and antioxidant defense. Thiamine contributes to energy metabolism through well-established biochemical pathways. Overall, these ingredients have a high safety profile based on available research.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacinamide: 85mg is 2.4× the Tolerable Upper Intake Level (35mg)

Folate: 714mg is 714.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Mega-One No Iron
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
61%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
3600 mcg (400% DV)
Vitamin C
250 mg (278% DV)
10 mcg (50% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
67 mg (447% DV)
4.5× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
85 mg (7084% DV)
70.8× RDA — above typical dose 76 studies (A:0, B:33)
85 mg (6539% DV)
65.4× RDA — above typical dose 13 studies (A:0, B:1)
85 mg (531% DV)
Exceeds UL by 2.4× (UL: 35 mg) 196 studies (A:5, B:63)
85 mg (5000% DV)
65.4× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
714 mcg DFE (179% DV)
Exceeds UL by 714.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
90 mcg (3750% DV)
37.5× RDA — above typical dose 139 studies (A:1, B:44)
Panthothenic Acid
85 mg (1620% DV)
33 mg (6% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Calcium
48 mg (4% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
20 mg (5% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
15 mg (136% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
50 mcg (91% DV)
Within RDA (0.9× RDA) 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
6 mg (261% DV)
2.6× RDA — within safe limits 9 studies — no high-quality reviews
100 mcg (286% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
100 mcg (222% DV)
2.2× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
10 mg (1% DV)
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
85 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
21 mg
Market median: 500.0mg (19 products)
Hespiridin
5 mg
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Stearic Acid modified Cellulose Gum Silica Biotin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 tablet daily with a meal.

Warnings & Precautions

Contains soy.

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

No iron

High potency multi-vitamin with minerals

MEGA-ONE is a potent one-tablet-a-day multi-vitamin.

Metadata

Product Details

UPC / SKU0 21078 01441 6
DSLD Entry Date2022-10-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID275354
Data Updated2026-04-11
Research

Research Evidence

566
Research Sources
56
Avg Quality
240
Meta Analysis
100
Clinical Trial
74
Systematic Review
71
Guideline
58
Rct
11
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
1
Observational
1
Openfda Safety
A Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Meta Analysis Nature medicine 2025 PubMed DOI
A Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Serum or plasma ferritin concentration as an index of iron deficiency and overload
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Non-invasive diagnostic tests for Helicobacter pylori infection
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
A Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Fortification of condiments and seasonings with iron for preventing anaemia and improving health
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
A Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2024 PubMed DOI
A Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review
Meta Analysis Neuroscience and biobehavioral reviews 2025 PubMed DOI
View all evidence for Iron →
Compare

Similar Products

View all Iron products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.